Corvex, Inc.

Listed Company
MOVECIK 0001734750NasdaqEmerging GrowthServices-Computer Processing & Data PreparationDelawareCHFY ends Dec 31
Period
FY 2025
Revenue
$433.0K
Net Income
$-18.29M
Total Assets
Equity
Shares Out
1.98M
Op. Cash Flow
$-11.27M

Business

Movano Inc. is developing a platform that brings medical-grade, high-quality biometric data to consumer health devices to enable preventative care and clinical monitoring. It offers wearable products including the Evie Ring (consumer wellness) and the FDA-cleared EvieMED Ring (prescription medical device), a mobile app, cloud analytics, and a patented RF-enabled System-on-a-Chip designed for non-invasive continuous glucose and cuffless blood pressure monitoring. Its activities span product development, clinical studies, regulatory submissions, intellectual property and manufacturing partnerships. It sells direct-to-consumer online, via prescription to healthcare providers and payors, and pursues OEM, VAR and clinical trial channels domestically and internationally.

Summary from filing dated 2025-04-09

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts
ConceptTrend
FY 2025
2025-12-31
FY 2024
2024-12-31
FY 2023
2023-12-31
FY 2022
2022-12-31
FY 2021
2021-12-31
Revenue433,0001
Cost of revenue23
Research and development611171913
Sales, general and administrative81113116
Total costs and expenses162530
Loss from operations−16−24−30−30−20
Interest expense (related party)−3
Interest and other income, net183,000495,000407,000
Other income (expense), net−3495,000407,000133,000
Net loss and total comprehensive loss−18−24−29−30−22
Cumulative dividends on Series A preferred stock−37,000
Net loss - attributed to common stockholders−18−24−30−24
Net loss per share, basic (in Dollars per share)−21.79−39.39−9.51−0.92−0.92
Net loss per share, diluted (in Dollars per share)−21.79−39.39−9.51−0.92−0.92
Weighted average shares used in computing net loss per share, basic (in Shares)840,720602,33333326
Weighted average shares used in computing net loss per share, diluted (in Shares)840,720602,33333326

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro